References:
  1. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 395: 565-574, 2020.
  2. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395: 1033-1034, 2020.
  3. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic. J Am Coll Cardiol 2020 Mar 18. doi: 10.1016/j.jacc.2020.03.031
  4. Darlenski R, Tsankov N. COVID-19 pandemic and the skin: what should dermatologists know? Clin Dermatol 2020 Mar 24. https://doi.org/10.1016/j.clindermatol.2020.03.012
  5. Weinkove R, McQuilten ZK, Adler J et al. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance. Med J Aust 2020 May 13. doi: 10.5694/mja2.50607
  6. Amanda C. Guidon, Anthony A. Amato. COVID-19 and neuromuscular disorders. Neurology 2020 Apr 13. doi:10.1212/WNL.0000000000009566
  7. Liang W, Guan W, Chen R et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21: 335–7, 2020.
  8. Yu J, Ouyang W, Chua MLK et al. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol 6(7): 1108-1110, 2020.
  9. James AH, Cooper DL, Paidas MJ. Hemostatic assessment, treatment strategies, and hematology consultation in massive postpartum hemorrhage: results of a quantitative survey of obstetrician-gynecologists. Int J Womens Health 4(7): 873-881, 2015.
  10. Fox TA,  Troy-Barnes E,  Kirkwood AA et al. Clinical outcomes and risk factors for severe COVID-19 infection in patients with haematological disorders receiving chemo- or immunotherapy. Br J Haematol 2020 Jul 17. doi: 10.1111/bjh.17027
  11. He W, Chen L, Chen L et al. COVID-19 in persons with haematological cancers. Leukemia 34: 1637-1645, 2020.
  12. Parnas M, Sheiner E, Shoham-Vardi I et al. Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol 128(1-2):163-168, 2006.
  13. Ten Berg MJ, van den Bemt PM, Shantakumar S et al. Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: results from a retrospective hospital-based cohort study. Drug Saf 34: 1151–1160, 2011.
  14. Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395: 497–506, 2020.
  15. Fan BE, Chong VCL, Chan SSW et al. Hematologic parameters in patients with COVID‐19 infection. Am J Hematol 2020 Mar 04. doi:https://doi.org/10.1002/ajh.25774.
  16. Terpos E, Ntanasis-Stathopoulos L, Elalamy I et al. Hematological findings and complications of COVID-19. Am J Hematol 95: 834–847, 2020.
  17. Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395: 1054–1062, 2020.
  18. Han H, Yang L, Liu R et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 2020 Jun 25. doi:https://doi.org/10.1515/cclm-2020-0188.